Concepedia

Cell Cycle-specific Agents

Cell Cycle-Specific Agents is a class of cytotoxic chemotherapeutic agents that exert their antineoplastic effects selectively during particular phases of the cell cycle, distinguishing them from non-specific agents by their dependency on active cell proliferation and phase-specific metabolic activity.

209

Publications

10.5K

Citations

850

Authors

274

Institutions

Publications per year

2017–2026

14

Variants

Cell Cycle-specific Chemotherapeutic AgentsCell Cycle-specific Drugs

Parents

Publications

209

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

Manish A. Shah, Gary K. Schwartz · PubMed · 2001 · 440 citations

, , +17

Concepts for systemic treatment of micrometastases

F. M. Schabel · Cancer · 1975 · 332 citations · Full text

, , +16

Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.

Skipper He, Schabel Fm, Wilcox Ws · PubMed · 1967 · 233 citations

, , +9

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.

Thomas W. Pendergrass, Jerrold M. Milstein, J. Russell Geyer et al. · Journal of Clinical Oncology · 1987 · 220 citations

, , +17

Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin

Robert C. Gallo, Jacqueline Whang‐Peng, Richard H. Adamson · JNCI Journal of the National Cancer Institute · 1971 · 216 citations

, , +14

1–5 of 209

Authors

850

  1. BD
    Benjamin Drewinko

    The University of Texas System, United States

    5 publications · 226 citations

    5

    h-index

  2. ZA
    Zvia Agur

    Institute for Medical BioMathematics, Israel

    4 publications · 234 citations

    4

    h-index

  3. MI
    Makoto Inaba

    Japanese Foundation For Cancer Research, Japan

    4 publications · 197 citations

    4

    h-index

  4. SC
    S. C. Barranco

    The University of Texas Medical Branch at Galveston, United States

    3 publications · 71 citations

    3

    h-index

  5. AŚ
    Andrzej Świerniak

    Silesian University of Technology, Poland

    3 publications · 219 citations

    3

    h-index

1–5 of 850

Institutions

274

  1. Japanese Foundation For Cancer Research

    Tokyo, Japan

    7 h-index

    11 publications

    434 citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    6 h-index

    11 publications

    1K citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    5 h-index

    13 publications

    861 citations

  4. National Cancer Institute

    Bethesda, United States

    5 h-index

    11 publications

    1.4K citations

  5. University of Bologna

    Bologna, Italy

    3 h-index

    13 publications

    591 citations

  6. The University of Tokyo

    Tokyo, Japan

    3 h-index

    3 publications

    133 citations

  7. Johns Hopkins University

    Baltimore, United States

    3 h-index

    7 publications

    433 citations

  8. Emory University

    Atlanta, United States

    3 h-index

    8 publications

    414 citations

1–8 of 274

Venues

  1. PubMed

    Repository · 71 publications · 3.9K citations

    32

    h-index

  2. JNCI Journal of the National Cancer Institute

    7 publications · 536 citations

    7

    h-index

  3. Cancer

    7 publications · 533 citations

    7

    h-index

  4. Molecular Pharmacology

    4 publications · 75 citations

    4

    h-index

  5. Cancer Chemotherapy and Pharmacology

    4 publications · 224 citations

    4

    h-index

1–5